Saturday 17 October 2026
Export ELTX’s income statement to Excel — free account
Elicio Therapeutics, Inc.
ELTX Healthcare Biotechnology
In the quarter to June 2026, EPS grew 34.9%, free cash flow grew 8.77% and total debt rose 2.12%, each against the same quarter a year earlier.
1.56
0.22
−12.36%
Follow ELTX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
2.55 | 2.07 | 2.29 | 3.16 | |
Current Ratio |
2.77 | 2.24 | 2.38 | 3.29 | |
Net Debt/EBITDA |
1.38 | 0.53 | 1.09 | 1.40 | |
Debt/Assets |
30.43% | 41.76% | 36.37% | 34.37% | |
Debt/Equity |
1.20 | (6.59) | 5.75 | 2.55 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.99 | 0.98 | 0.88 | 1.10 | |
Capex/Depreciation |
0.00 | 0.00 | (0.03) | 0.00 | |
Interest Coverage |
(25.44) | (26.05) | (26.24) | (18.88) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.42) | (0.64) | (0.44) | (0.66) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.42) | (0.64) | (0.44) | (0.66) | |
Cash per Share |
1.22 | 0.82 | 1.21 | 1.23 | |
Shareholders Equity per Share |
0.41 | (0.08) | 0.11 | 0.23 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.41 | (0.08) | 0.11 | 0.23 | |
Free Cash Flow |
(8.16) | (11.64) | (6.81) | (11.09) | |
Working Capital |
16.28 | 8.97 | 11.20 | 14.95 | |
Capital Expenditures |
— | — | (0.02) | — | |
Net Current Asset Value |
2.09 | (7.93) | (4.91) | (3.00) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | 0.00 | — | |
| Other line items | |||||
Average Payables |
2.35 | 2.15 | 0.86 | 1.15 | |
Average Assets |
30.43 | 25.42 | 27.02 | 33.34 | |
Average Common Equity |
4.89 | 3.73 | (4.84) | (7.58) |
Columns are period end dates